Hemo Organic Board to Consider Fund Raising on Sep 23, 2026

Hemo Organic Ltd has announced that its Board of Directors will convene on September 23, 2026, to discuss and approve a proposal for raising funds. The fund-raising initiative may involve issuing equity shares and/or convertible securities, including warrants, through various methods such as preferential allotment, private placement, QIP, rights issue, or further public issue. The company will also seek shareholder approval for these actions. Concurrently, the trading window for designated persons will be closed from September 19, 2026, until 48 hours after the board meeting concludes, in compliance with SEBI's insider trading regulations.